oseltamivir has been researched along with thiazoles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Belardo, G; Cenciarelli, O; La Frazia, S; Rossignol, JF; Santoro, MG | 1 |
| Araujo-Meléndez, J; Beigel, JH; Galindo-Fraga, A; Gamiño-Arroyo, AE; García-Andrade, LA; Guerrero, ML; Holley, HP; Hunsberger, S; Ibarra-González, V; Kapushoc, H; Llamosas-Gallardo, B; Martínez-López, J; McCarthy, S; Moreno-Espinosa, S; Ramírez-Venegas, A; Roldán-Aragón, Y; Ruiz-Palacios, GM; Smolskis, MC | 1 |
| Hurt, AC; Mifsud, EJ; Ming-Kay Tai, C; Oh, DY; Rossignol, JF; Tilmanis, D | 1 |
| Barr, IG; Hurt, AC; Koszalka, P; Mifsud, E; Rossignol, JF; Tilmanis, D | 1 |
| Hensen, L; Hurt, AC; Kedzierska, K; Kedzierski, L; Koutsakos, M; Mercuri, F; Mifsud, E; Nüssing, S; Rossignol, JF; Wang, Z | 1 |
| Chen, Y; Ding, M; Jiang, X; Lan, K; Lavillete, D; Li, H; Li, S; Liu, Y; Shan, J; Shang, W; Shen, Z; Sun, Y; Tong, Y; Wang, R; Wang, Y; Wu, Y; Xiao, G; Xiong, R; Xu, K; Xu, L; Zhang, L; Zhao, Y; Zhao, Z; Zhu, L; Zou, G | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
1 review(s) available for oseltamivir and thiazoles
| Article | Year |
|---|---|
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
1 trial(s) available for oseltamivir and thiazoles
| Article | Year |
|---|---|
Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Double-Blind Method; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitro Compounds; Oseltamivir; Severe Acute Respiratory Syndrome; Thiazoles; Treatment Outcome; Young Adult; Zanamivir | 2019 |
5 other study(ies) available for oseltamivir and thiazoles
| Article | Year |
|---|---|
Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Topics: Antiviral Agents; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H7N1 Subtype; Neuraminidase; Nitro Compounds; Oseltamivir; Thiazoles; Zanamivir | 2015 |
Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy.
Topics: Administration, Oral; Animals; Antiviral Agents; Chemoprevention; Dogs; Drug Combinations; Drug Resistance, Viral; Female; Ferrets; Influenza A Virus, H1N1 Subtype; Lung; Madin Darby Canine Kidney Cells; Male; Nitro Compounds; Orthomyxoviridae Infections; Oseltamivir; Thiazoles; Virus Shedding | 2020 |
Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
Topics: Animals; Antiviral Agents; Cell Proliferation; Dogs; Drug Resistance, Viral; Drug Therapy, Combination; Female; Ferrets; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Male; Nitro Compounds; Orthomyxoviridae Infections; Oseltamivir; Thiazoles | 2020 |
Viral burden, inflammatory milieu and CD8
Topics: Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; CD8-Positive T-Lymphocytes; Cytokines; Inflammation; Influenza A virus; Killer Cells, Natural; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Oseltamivir; Thiazoles; Viral Load; Weight Loss | 2020 |
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Topics: Animals; Antiviral Agents; Betacoronavirus; Binding Sites; Cell Line; Coronavirus Infections; COVID-19; Crotonates; Cytokine Release Syndrome; Dihydroorotate Dehydrogenase; Drug Evaluation, Preclinical; Gene Knockout Techniques; Humans; Hydroxybutyrates; Influenza A virus; Leflunomide; Mice; Mice, Inbred BALB C; Nitriles; Orthomyxoviridae Infections; Oseltamivir; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pandemics; Pneumonia, Viral; Protein Binding; Pyrimidines; RNA Viruses; SARS-CoV-2; Structure-Activity Relationship; Thiazoles; Toluidines; Ubiquinone; Virus Replication | 2020 |